Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 16, 2022 4:00 P.M.
Form: S-3
CIK: 0001720893
Company Name: BioXcel Therapeutics, Inc.
File Number: 333-265277